No Data
No Data
Express News | GlycoMimetics Inc -on June 21, Got Notice From Nasdaq, Co Is Not in Compliance With Nasdaq’s Listing Rule 5450(a)(1)
Senior VP & Chief Medical Officer of GlycoMimetics Edwin Rock Buys 81% More Shares
Even if it's not a huge purchase, we think it was good to see that Edwin Rock, the Senior VP & Chief Medical Officer of GlycoMimetics, Inc. (NASDAQ:GLYC) recently shelled out US$79k to buy stock, at U
Beyond Air XAIR Earnings; GlycoMimetics GLYC Insider Buys
Why GlycoMimetics Stock Is Trading Higher Monday
GlycoMimetics, Inc. (NASDAQ:GLYC) stock is moving higher Monday after its chief medical officer disclosed the purchase of company stock. The Details: On Tuesday, the chief medical officer Edwin Rock
GlycoMimetics Shares Are Trading Higher After the Company Disclosed That Chief Medical Officer Edwin Rock Bought 305,000 Shares at an Average Price of $0.26 per Share.
GlycoMimetics Shares Are Trading Higher After the Company Disclosed That Chief Medical Officer Edwin Rock Bought 305,000 Shares at an Average Price of $0.26 per Share.
GlycoMimetics(GLYC.US) Officer Buys US$78,824.5 in Common Stock
$GlycoMimetics(GLYC.US)$ Officer Rock Edwin purchased 305K shares of common stock on Jun 20, 21, 2024 at an average price of $0.2584 for a total value of $78,824.5.Source: Announcement What is stateme